戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 ( left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                             No change in (99m)Tc-linear duramycin uptake could be detecte
2                                                             No change in care plan concordance or resource utilization.
3                                                             No change in peak Vo2 occurred at 2 weeks in patients with re
4                                                             No changes in insulin or c-peptide were detected.
5                                                             No changes in structural propensities of 4E-BP2 dissolved in
6                                                             No changes in villus height/crypt depth were observed.
7                                  However, there were almost no changes in food intake and body weight when wortmannin inj
8 r contacts, H-NS binding is significantly reduced, although no change in chromosome compaction is observed.
9 4 [95% CI, 0.62-1.42]; p = 0.77; low-quality evidence), and no change in the duration of mechanical ventilation (mean dif
10  RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting
11 hyperpolarized voltages resulted in a reduction of fres but no change in QZ.
12 f the PM pool of NHE3 in only the internal PBM mutation but no change in total NHE3 half-life in either.
13 nce, reduced RDT positivity within symptomatic patients but no change in the number of antimalarial treatments due to fal
14 ctional coupling between BKCa alpha and beta1 subunits, but no change in total protein abundance.
15 ked the tastes of carrot, beet, and celery juices more, but no changes in dietary intake of vegetables were observed.Earl
16 osition of RNAPII-Ser5P, the initiating form of RNAPII, but no changes in H3K27me3, at the promoters of affected endocrin
17                              Metabolomic analysis confirmed no change in cellular metabolic response to a range of osmoly
18                                                     Despite no change in the scheduled age of varicella vaccine, use of M
19  resolution of symptoms attributed to ECD), stable disease (no change in symptoms attributed to ECD), and progressive dis
20 ; the results show that the cells stored at 2.3 V exhibited no change in cell capacity after 90 days; resistance rise was
21             However, ex vivo analyses from this study found no change in the capacity of CMV pp65-specific T cells to gai
22                                                    Further, no changes in thermal stability were observed between enzymes
23  associated with increased osteoclast (OC) numbers, but had no change in osteoblast numbers or bone formation rate.
24                                       All the emulsions had no change in their particle size during storage (28days at 5,
25                                         There was, however, no change in microcirculation inflammation, gene expression p
26                                                    However, no changes in beta-carotene and lycopene bioaccessibility wer
27 cross 5 orders of magnitude in macroscale modulus, there is no change in adhesion.
28 noses of DJD, progression was observed in 122 (15%) joints, no change in 564 (71%), and reversal in 108 (14%).
29 r than baseline pre-TAVR), worsened eGFR (>/=10% lower), or no change in renal function (neither).
30 ntroversial, with studies showing increasing, decreasing or no changes in motor activity.
31 s employing immunofluorescence antibody-based assays reveal no changes in H3K4me3 levels in cells ectopically overexpress
32 properties of GluN2B S1413L in recombinant systems revealed no change in receptor properties, consistent with synaptic de
33            While the PfRh2b deletion transgenic line showed no change in invasion pathway utilization compared to the wil
34 erall effect on perinatal mortality, while the other showed no change in perinatal mortality.
35 more, CD73 inhibition and enzyme replacement studies showed no change in total kidney adenosine levels in treated mice co
36 hose patients receiving primary surgery as treatment showed no change in mortality when performed by HV cancer surgeons.H
37 tolerance and beta-cell insulin secretion defect but showed no changes in beta-cell mass.
38 donor under exceptional medical circumstances and therefore no change in legislation is required to increase utilization
39                                                   There was no change in gamma-H2AX or pATM expression after open repair.
40                                          However, there was no change in maximum force or the titin N2BA/N2B isoform rati
41                                                   There was no change in recall examinations for calcifications (P = .977
42                                                   There was no change in the median NADAC price or the number of manufact
43                                         Finally, there were no changes in intrinsic excitability of any region in rats ex
44           Contrary to developmental myelination, there were no changes in OPC or oligodendrocyte numbers in either model.
45  year 3 (mean+/-SD 5.8+/-3.5 to 7.55+/-4.6, p<0.0001), with no change in HC.
46  VTA, this was due to increased NMDA receptor function with no change in AMPA receptor function.
47 mediated NCC phosphorylation in Nedd4L(Pax8/LC1) mice, with no change in total NCC.
48 kout mice, FlnC protein levels were highly upregulated with no change in transcription, and we further demonstrated that
49 time-dependent activation of the lysosomal compartment with no changes in LC3 expression was detected.
50 rin-1) and postsynaptic signaling (e.g., GluA1, PRRT2) with no changes in synaptic GABAergic proteins.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。